CENTER Laboratories Inc. was established in 1959, specialized in the supply chain of oral liquid pharmaceutical products. CENTER Laboratories Inc. is currently the largest oral solution manufacturer and the leader in pediatric liquid medication in Taiwan with advanced technique and professional formulation design and analysis.
In 2008, CENTER Laboratories Inc. branched out into the central nerves system field with developments of CNS and special drugs portfolio. We recharacterize CENTER Laboratories Inc. as a industrial bank for technology and establish BioEngine Venture Capital Inc. to dedicate to invest and raise the biotechnical industry.
CENTER Laboratories Inc. intends to be "the most professional pharmaceutical company for oral solution and the leader in CNS field in Asia". With this vision, we organize various recourses of R&D, clinical, regulatory, production and marketing and strengthen development of personalized/region-specific products to lead CENTER Laboratories Inc. not only to be the leader in oral liquid medication and CNS field, but the expert in differentiated /personalized medication. With the root of oral liquid medicine and CNS drug in Asia, geared to international convention by differentiated / personalized product, and through capital integration techniques, talents, as well as industry management experience, strategic investment in biotechnology industry, we successfully brought a number of innovative biotechnology companies which will soon be listed on TSE via OTC counselling and we will gradually achieve the long-term goals of the「industrial Bank of biotech and cradle of biotech industry」.